NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced that company management will participate in two upcoming institutional investor conferences in March, including live presentations and one-on-one meetings with investors.
The company said it will take part in the TD Cowen 46th Annual Health Care Conference in Boston from March 2 to March 4. Management is scheduled to participate in a live fireside chat at 9:50 a.m. Eastern Time on Tuesday, March 3.
Orchestra BioMed will also participate in the Barclays 28th Annual Global Healthcare Conference in Miami from March 10 to March 12. A live fireside chat is scheduled for 8:00 a.m. Eastern Time on Wednesday, March 11.
The company said live webcasts of both presentations will be available through links provided on its Investor Relations website, with replays accessible following the events.
Orchestra BioMed is a biomedical company developing technologies in collaboration with global medical device manufacturers. Its lead product candidates include Atrioventricular Interval Modulation (AVIM) Therapy, a bioelectronic treatment for hypertension being developed with Medtronic, and the Virtue® Sirolimus AngioInfusion™ Balloon, an investigational drug delivery system for the treatment of atherosclerotic artery disease.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.